{"id":"W4313553529","doi":"10.1200/jco.22.02331","title":"Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Nivolumab; Pembrolizumab; Internal medicine; Trastuzumab; Ramucirumab; Oncology; Ipilimumab; Cancer; Targeted therapy; Esophageal cancer; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Immunotherapy; Progressive disease; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009429664,0.001666134,0.003777688,0.004805,0.000863737,0.002131914,0.005521559,0.005540133,0.005858136],"category_scores_gemma":[0.02258811,0.0007814387,0.00638485,0.004667333,0.0009107409,0.002026862,0.00211524,0.004399639,0.004165097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004553053,"about_ca_system_score_gemma":0.0174557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01750595,"about_ca_topic_score_gemma":0.02577494,"domain_scores_codex":[0.9903888,0.003414124,0.003282574,0.0004392611,0.00210567,0.0003696142],"domain_scores_gemma":[0.9852843,0.003969406,0.0034114,0.0003721786,0.006185902,0.0007769011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002420635,0.00009436699,0.001170182,0.1124701,0.00152292,0.0002636555,0.0002545835,0.001303467,0.0008123174,0.004718487,0.6408458,0.236302],"study_design_scores_gemma":[0.0006901812,0.0001761245,0.00371947,0.2618415,0.003968915,0.0006358137,0.0001191675,0.000691981,0.0003891018,0.005622838,0.7220615,0.00008351984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001556432,0.8162127,0.009103616,0.1074286,0.01071596,0.005514132,0.01687852,0.0005047203,0.03208538],"genre_scores_gemma":[0.01290826,0.8097467,0.05504069,0.07193708,0.004613476,0.00811047,0.02443803,0.0001985906,0.01300658],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01750595,"threshold_uncertainty_score":0.04986942,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2375949059476379,"score_gpt":0.5638737964619235,"score_spread":0.3262788905142856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}